Skip to content

Development and validation of a prognostic model for predicting exacerbations of erythrodermic psoriasis

Development and validation of a prognostic model for predicting exacerbations of erythrodermic psoriasis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500109797
Enrollment
Unknown
Registered
2025-09-25
Start date
2025-10-01
Completion date
Unknown
Last updated
2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psoriasis

Interventions

Psoriasis Observation group:None

Sponsors

Southern Medical University Hospital of Dermatology (Guangdong Provincial Hospital of Dermatology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Males or females aged >=18 years; 2.Meets the definition of severe psoriasis as follows: Psoriasis Area and Severity Index (PASI) score >=10; Body Surface Area (BSA) involved >=10 %; 3.Skin manifestations: diffuse flushing of the skin over =75% of the body, with small patches of normal skin in the diffuse erythema.

Exclusion criteria

Exclusion criteria: 1.Pregnant, preparing for pregnancy, breastfeeding patients; 2.The patient was enrolled in another clinical trial during the visit and it may have affected data collection for this study; 3.Other conditions that, in the opinion of the investigator, make enrolment inappropriate; 4.Data quality and completeness: Retrospective data may be missing, contradictory or unreliable.

Design outcomes

Primary

MeasureTime frame
Psoriasis Area and Severity Index;

Countries

China

Contacts

Public ContactYongfeng chen

Southern Medical University Hospital of Dermatology (Guangdong Provincial Hospital of Dermatology

gdcyf@163.com+86 20 8725 5081

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026